Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|September 15, 2009
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitisGeorge Philip, Janet van Adelsberg, Thomas Loeys, et al.
Allergy and Asthma Proceedings|April 9, 2005
Onset of efficacy of montelukast in seasonal allergic rhinitisSteven F Weinstein, George Philip, Frank C Hampel, et al.
Allergy and Asthma Proceedings|January 7, 2012
Onset and duration of attenuation of exercise-induced bronchoconstriction in children by single-dose of montelukastYasmine S Wasfi, James P Kemp, César Villarán, et al.
Allergy & Rhinology (Providence, R.I.)|July 21, 2018
Evaluation of Montelukast for the Treatment of Children With Japanese Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO Chamber)Kazuhiro Hashiguchi, Kimihiro Okubo, Yoichi Inoue, et al.
The British Journal of Radiology|January 24, 2024
Diagnostic accuracy of dual-energy computed tomography in the diagnosis of neurological complications after endovascular treatment of acute ischaemic stroke: a systematic review and meta-analysisNoha Yahia Ebaid, Adel Mouffokes, Noha S Yasen, et al.
Digital Health|November 24, 2025
Exploring the usability and perceived benefits of Brain Health PRO: An online educational program for healthy brain agingGeorge Philip, Alexandra J Fiocco, Sylvie Belleville, et al.
Rheumatology (Oxford, England)|April 20, 2021
Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: results from open-label extensionDésirée van der Heijde, Maxime Dougados, Walter P Maksymowych, et al.
Journal of Drug Assessment|October 28, 2016
Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trialKimihiro Okubo, Yoichi Inoue, Hirotaka Numaguchi, et al.
European Journal of Gastroenterology & Hepatology|April 12, 2022
Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational studyMarc Ferrante, Anja Schirbel, Marieke J Pierik, et al.
Rheumatology (Oxford, England)|March 15, 2023
Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK)Cindy L J Weinstein, Paula Sliwinska-Stanczyk, Tomas Hála, et al.
Pageof 6